Echinococcus multilocularis in North America: the great unknown by Massolo, Alessandro et al.
Echinococcus multilocularis in North America: the great
unknown
Alessandro Massolo1,*, Stefano Liccioli1,2, Christine Budke3, and Claudia Klein4
1 Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada
2 Department of Biological Sciences, Faculty of Sciences, University of Calgary, Calgary, Alberta, Canada
3 Department of Veterinary Integrative Biosciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University,
College Station, Texas, USA
4 Department of Veterinary Clinical and Diagnostic Sciences, Faculty of Veterinary Medicine, University of Calgary, Calgary,
Alberta, Canada
Received 4 August 2014, Accepted 11 December 2014, Published online 23 December 2014
Abstract – Over the last decade, studies have begun to shed light on the distribution and genetic characterization of
Echinococcus multilocularis, the causative agent of alveolar echinococcosis (AE), in North America. Recent findings
indicate that the parasite is likely expanding its range in the central region of the United States and Canada and that
invasions of European strains might have occurred. In our review, we present the available data on E. multilocularis
infections in wild and domestic animals and humans in North America and emphasize the lack of knowledge on the
distribution of the parasite in wild and domestic hosts. Furthermore, we stress the need to better understand the com-
plexity of host communities and their roles in shaping the transmission and distribution of the parasite. We hypoth-
esize that a lack of knowledge about AE by North American physicians might result in the misdiagnosis of cases and
an underestimation of disease incidence. The endemic presence of the parasite in urban areas and a recent human case
in Alberta, Canada, suggest that the scientific community may need to reconsider the local public health risks,
re-assess past cases that might have been overlooked and increase surveillance efforts to identify new cases of human
AE.
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Résumé – Echinococcus multilocularis en Amérique du Nord : le grand inconnu. Au cours des dernières
décennies, un certain nombre d’études a commencé à apporter quelques éclaircissements sur la distribution et la
caractérisation génétique d’Echinococcus multilocularis, l’agent causal de l’échinococcose alvéolaire (EA), en
Amérique du Nord. D’après les résultats les plus récents, le parasite est en train d’étendre son territoire au sein
des régions centrales des États-Unis et du Canada, et il semble que l’on assiste à une invasion par des souches
européennes. Dans cette revue générale, nous présentons les données actuellement disponibles sur l’infection par
E. multilocularis chez les hôtes sauvages et domestiques en Amérique du Nord, et soulignons notre manque de
connaissance concernant la distribution du parasite entre ces hôtes sauvages et domestiques. De plus, nous
insistons sur la nécessité de mieux comprendre la complexité des communautés d’hôtes et leur rôle respectif dans
la transmission et la distribution du parasite. Nous faisons l’hypothèse que l’absence de connaissance de l’EA par
les médecins nord-américains est à l’origine de diagnostics erronés et donc d’une sous-estimation de l’incidence
de la maladie. La présence endémique du parasite dans les zones urbaines, et un cas humain récent dans
l’Alberta, au Canada, suggèrent que la communauté scientifique aurait peut-être intérêt à reconsidérer les risques
locaux pour la santé publique, à reprendre l’évaluation diagnostique de cas qui auraient pu être négligés par le
passé, et à renforcer la surveillance pour identifier de nouveaux cas humains d’EA.
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Introduction
Alveolar Echinococcosis (AE), a zoonosis caused by the
tapeworm Echinococcus multilocularis, is recognized as an
important emerging parasitic disease in the northern hemi-
sphere [21, 88], and recently ranked as the third most relevant
food-borne parasitic zoonosis [23]. The disease is estimated to
affect more than 18,000 people per year globally, with most
cases located in Europe and Asia [84]. China is believed to
have the largest number of AE cases, with one study estimating
that Chinese cases comprise approximately 91% of the global
burden [88]. A recent study on the genetic characterization of
E. multilocularis mitochondrial DNA [62] identified three
strains corresponding to the geographical regions of Asia,
Europe, and North America [18]. In North America, two
sub-strains have been reported (N1 in the tundra zone and
N2 in the central region) [62], supporting previous reports that
parasites from Alaska and the north-central states of Montana
and North Dakota differed in the development of their larval
stages [5, 72].
Locally acquired human AE in North America has always
been considered very rare, most cases historically reported
being due to extra-continental infections (i.e. patients with tra-
vel history outside North America), with the important excep-
tion of a historical hotspot of the Asian strain that was
discovered in St. Lawrence Island, Alaska, in the 1940s [78,
92]. To date, only three human cases are believed to have been
caused by the central region strain of E. multilocularis, the first
one in 1928 (Manitoba, Canada; [38]), the second in 1977
(Minnesota, USA; [26]), and the most recent in 2013 (Alberta,
Canada; personal communication, Kinga T. Kowalewska-
Grochowska). Despite an increased awareness of echinococco-
sis and other neglected tropical diseases, it is still unknown if
AE is truly a rare disease in North America or if cases are
being misdiagnosed due to a lack of physician knowledge
about the disease [9, 92].
This review focuses on the available data on the presence
of E. multilocularis in wild and domestic hosts and humans
in North America, with the specific objectives of (1) identify-
ing knowledge gaps in the parasite’s spatial distribution in wild
and domestic host species, (2) providing a summary of avail-
able data on human infections, (3) illustrating the genetic
characterization of E. multilocularis in North America, and
(4) discussing possible emerging public health risks.
Echinococcus multilocularis in wild hosts
Since the 1950s, several studies have been carried out to
establish the primary wildlife hosts of E. multilocularis in
North America, focusing on the Alaskan peninsula, Minnesota,
and North Dakota, USA (e.g. [52, 53, 58, 70]) as well as
Alberta, Canada [35]. However, despite the relevance of the
parasite worldwide, and the groundbreaking initial work con-
ducted by Rausch and Leiby [24, 26, 42, 50–54, 67, 68,
70–73, 79], the distribution, ecology, and epidemiology of
E. multilocularis in North America is still largely unknown.
In North America, E. multilocularis has been reported in the
northern tundra zone (NTZ) of Alaska and Canada, and in
the north central region (NCR), including four Canadian
Provinces (Alberta, Saskatchewan, Manitoba, and British
Columbia) and 13 US states (North Dakota, South Dakota,
Iowa, Minnesota, Montana, Wyoming, Nebraska, Illinois,
Wisconsin, Indiana, Ohio, and Missouri, and more recently
central and southwestern Michigan) [18, 40, 84, 85] (Table 1).
The parasite is typically maintained in a sylvatic life cycle
[22], with regional hosts determined by local predator-prey
communities. In the NTZ, the parasite’s life cycle is sustained
by the arctic fox (Vulpes lagopus) and its arvicoline rodent prey
species such as the northern vole (Microtus oeconomus), the
brown lemming (Lemmus sibiricus), and the northern red-
backed vole (Myodes rutilus) [22]. Other carnivore species
such as wolves (Canis lupus) may also harbor E. multilocularis,
however, their role in parasite transmission has not been fully
evaluated [80]. In the NCR, which is mostly characterized by
prairie and boreal forests, the red fox (Vulpes vulpes) and the
coyote (Canis latrans) are the primary definitive hosts, which
prey on intermediate host species such as the deer mouse
(Peromyscus maniculatus) and the meadow vole
(Microtus pennsylvanicus) [35, 53]. The house mouse (Mus
musculus) [51], the bushy tailed woodrat (Neotoma cinerea)
[51, 53, 54], and the southern red-backed vole (Myodes gap-
peri) are other intermediate hosts of possible local importance
[56].
Despite having a predominantly sylvatic life cycle, domes-
tic animals can contribute to parasite transmission, resulting in
the development of semi-synanthropic foci [22]. The most
notable example of this, in North America, occurred in Native
American communities on St. Lawrence Island, Alaska where
domestic dogs were becoming infected by ingesting infected
small mammals [77]. Another possible example is the case
of two infected cats and an infected house mouse from a farm
in North Dakota [54]. Although the authors speculated on the
existence of a synanthropic cycle (cat – house mouse) of
E. multilocularis, the alternative hypothesis that these latter
cases were simply a spill-over from a sylvatic life cycle cannot
be ruled out as no sampling from sylvatic hosts on the same
farm was attempted, and the parasite was found in wild hosts
no more than 13 km away from the farm. When a semi-
synanthropic cycle is present, zoonotic transmission is proba-
bly more likely to occur given the close association of humans
and domestic animals. Therefore, pet ownership can ultimately
represent a risk factor for AE infection in certain circumstances
[82]. Unfortunately, there has been a lack of consistency in the
collection of data on E. multilocularis in North America. This
lack of consistency is partially due to (1) variation in sampling
designs, (2) the use of different diagnostic techniques with dif-
fering sensitivities and specificities, (3) spatial and temporal
differences in data sources, and (4) regional differences in
definitive and intermediate host species communities.
Sampling design
Recent data from an urban area in North America indicate
that the distribution of E. multilocularis is spatially and
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Table 1. Echinococcus multilocularis infections in wild hosts in North America. Strains and haplotype as described in Nakao et al. [62].
Reference Location Definitive host Intermediate host
Species (prevalence; n) Method Strain Haplotype Species (prevalence; n) Strain Haplotype
Chalmers and Barrett
1974 [14]
Lethbridge, AB,
Canada
Peromyscus maniculatus (n/a)
Catalano et al. 2012 [13] Calgary, AB,
Canada
Canis latrans (20.5%; 83) Intestine n/a
Liccioli et al. 2012, 2013
[55, 56]
Calgary, AB,
Canada
Canis latrans (29.5%; 61) Intestine
Canis latrans (21.4%; 385) Feces Peromyscus maniculatus (0.7%; 305)
Microtus pennsylvanicus (0.7%; 267)
Mus musculus (0%; 2)
Myodes gapperi (1.4%; 71)
Sorex sp. (0%; 296)
Zapus princeps (0%; 32)
Spermophilus tridecemlineatus (0%; 6)
Tamias minimus (0%; 4)
Thomomys talpoides (0%; 3)
Holmes et al. 1971 [35] Edmonton, AB,
Canada
Peromyscus maniculatus (27.7%; 216)
Myodes gapperi (0%; 122)
Microtus pennsylvanicus (0%; 1)
Catalano et al. 2012 [13] Edmonton, AB,
Canada
Canis latrans (62.5%; 8) Intestine n/a
Gesy et al. 2014 [28] Edmonton, AB,
Canada
Canis latrans (n/a) Intestine E, F
Gesy et al. 2013 [27] Quesnel, BC,
Canada
Canis latrans (37%; 27) Intestine E Peromyscus maniculatus (0%; 72)
Vulpes vulpes (17%; 6) Intestine E Microtus pennsylvanicus (0%; 59) E
Gesy et al. 2014 [28] 100 Mile House,
BC, Canada
Microtus pennsylvanicus (0%; 59)
Zapus hudsonius (0%; 16)
Sorex spp. (0%; 7)
Gesy et al. 2014 [28] Quesnel, BC, Canada Canis latrans (37%; 27) Intestine D, E, L, M
Vulpes vulpes (17%; 6) Intestine
Gesy et al. 2014 [28] Sathu, NT, Canada Canis lupus (8%; 73) Intestine A, G, H
Gesy et al. 2014 [28] SK, Canada Canis lupus (24%; 17) Intestine A, I Peromyscus maniculatus (5%; 783) A, I, J, K
Gesy et al. 2014 [28] Riding Mtn, MB,
Canada
Canis lupus (67%; 3) Intestine A, E
Gesy et al. 2014 [28] Karrak Lake, NU,
Canada
Vulpes lagopus (4.8%; 354) Feces Myodes rutilus (0%; 8)
Lemmus trimucronatus (0%; 37)
Dicrostonyx groenlandicus (0%; 72)
Gesy et al. 2014 [28] Bylot Island, NU,
Canada
Vulpes lagopus (22%; 50) Feces A, E, N, O,
P, Q
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Table 1. (continued)
Definitive host Intermediate host
Reference Location Species (prevalence; n) Method Strain Haplotype Species (prevalence; n) Strain Haplotype
Schurer et al. 2014 [80] NT, Canada Canis lupus (8.2%; 73) Intestine E
Schurer et al. 2014 [80] SK, Canada Canis lupus (23.5%; 17) Intestine E
Schurer et al. 2014 [80] MB, Canada Canis lupus (67%; 3) Intestine E
Rausch et al. 1990 [70] AK, USA Vulpes lagopus (80%; 1579) Intestine
Kirk 2011 [44] AK, USA Vulpes lagopus (27%; 26) Intestine A2, A4
Holt et al. 2005 [37] Barrow, AK, USA Lemmus trimucronatus (0.9%; 467)
Dicrostonyx rubricatus (0%; 17)
Nakao et al. 2009 [62] AK, USA voles (n/a; 11) N1
Nakao et al. 2009 [62] Indiana, USA Vulpes vulpes (n/a) Intestine N2
Storandt et al. 2002 [85] NE, USA Vulpes vulpes (37.5%; 72) Intestine
Canis latrans (0%; 31) Intestine
Storandt et al. 2002 [85] KS, USA Vulpes vulpes (0%; 22) Intestine
Canis latrans (0%; 89) Intestine
Kritsky et al. 1977 [51] WY, USA Intestine Neotoma cinerea rupicola
Storandt et al. 2002 [85] WY, USA Vulpes vulpes (0%; 31) Intestine
Storandt and Kazacos
1993 [83]
IN, USA Vulpes vulpes (22%; 71) Intestine
Canis latrans (18.6%; 70) Intestine
Storandt and Kazacos
1993 [83]
IL, USA Canis latrans (35%; 17) Intestine
Storandt and Kazacos
2012 [84]
MI, USA Vulpes vulpes (4.1%; 97) Intestine
Ballard 1984 [2] WI, USA Vulpes vulpes (8.3%; 72) Intestine
Urocyon cinereoargenteus (0%; 31)
Carney and Leiby 1968 [12] MN, USA Vulpes vulpes Intestine Peromyscus maniculatus
Leiby et al. 1970, 1972
[53, 54]
MN, USA Vulpes vulpes (5%; 277) Intestine Peromyscus maniculatus (1.9%; 53)
Microtus pennsylvanicus (0%; 326)
Mus musculus (0%; 24)
Ballard and Vande
Vusse 1983 [3]
NE, IL, USA Vulpes vulpes (NE: 27%, 36;
IL: 10%, 40)
Intestine
Leiby et al. 1970 [53] SD, USA Vulpes vulpes (0.4%; 222) Intestine Peromyscus maniculatus (1.3%; 234)
Canis latrans (0%; 29) Intestine Microtus pennsylvanicus (0%; 67)
Mus musculus (0%; 4)
Schantz et al. 1995 [77] SD, USA Vulpes vulpes (0.45%; 222) Intestine
Hildreth et al. 2000 [34] SD, USA Canis latrans (44.4%; 9) Intestine
Vulpes vulpes (74.5%; 137) Intestine
Leiby et al. 1970 [53] ND, USA Vulpes vulpes (13.9%; 830) Intestine Peromyscus maniculatus (6%; 3335)
Canis latrans (6.3%; 111) Intestine Microtus pennsylvanicus (3.2%; 565)
Mus musculus (2.1%; 47)
Rausch and Richards
1971 [72]
ND, USA Vulpes vulpes (70%; 96) Intestine Peromyscus maniculatus (3%; 1080)
Hildreth et al. 1991 [33] ND, USA Vulpes vulpes (90%; 45) Intestine
(continued on next page)
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seasonally heterogeneous [57]. The frequent lack of an appro-
priate sampling design, which takes into account this spatio-
temporal variability, makes longitudinal analyses unreliable.
Moreover, while research conducted in Europe and Asia has
indicated that interannual fluctuations of intermediate hosts
are major drivers of E. multilocularis transmission [29, 30,
74], long-term studies in North America have mainly focused
on density-dependent processes regulating rodent populations
(e.g. [6, 47–49]). The available cross-sectional studies have
estimated local prevalence in definitive and intermediate hosts
(e.g. [13, 27, 35, 70]) in not well-defined host community sys-
tems. Therefore, trends in parasite transmission intensity and
distribution over time are not well understood.
When studies are conducted over a short period of time
(e.g. few months), it is not possible to take into account sea-
sonal variations or the age structure of the host populations
(e.g. [10]). Since it has been shown that significant variations
in prevalence can be detected across different seasons (e.g.
[10, 57]), surveys carried out over short periods of time and
over small spatial scales cannot be compared to longer term
studies carried out over large geographic areas. For example,
E. multilocularis infection in intermediate hosts is believed
to be highly clustered, resulting in prevalence as high as
10% in areas of only a few square meters, and less than
0.01% if calculated over larger areas in the same region [31].
For the above-mentioned reasons, it is necessary to consider
different spatial and temporal scales to provide an adequate
picture of the distribution of infections in a region, and be able
to compare it with other regions or other time points. Finally,
the origin of the samples can be a source of bias. For example,
the use of hunted [36], trapped [85], or road-killed [13] ani-
mals may lead to prevalence estimates that are not representa-
tive of the overall population and will, therefore, not be
comparable across studies.
Diagnostic techniques
Even when the same study designs have been used (e.g.
multiannual sampling of fox carcasses or feces), different diag-
nostic techniques with different sensitivities and specificities
were often applied to detect E. multilocularis infections in
definitive hosts. This is possibly related to the fact that studies
reporting E. multilocularis prevalence are, in most cases, broad
gastrointestinal parasite surveys (e.g. [36]) that use techniques
that may not specifically target E. multilocularis infection.
While there are methods available specifically for the detection
of adult Echinococcus spp. [18], caution should still be used
when comparing data obtained with different methodologies
that have different sensitivity and different precision in count-
ing worms per host.
The choice of diagnostic technique is important when
examining definitive host feces [55]. Fecal examination and
isolation of parasite eggs, for later molecular analysis, can be
conducted using sugar flotation [28, 55] or centrifugation and
sedimentation [57]. Although sugar flotation is commonly used
for surveying gastrointestinal parasites in dogs and wild canids
[75, 90], its sensitivity in detecting E. multilocularis in coyote
feces was shown to be considerably lower than that reported forTa
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the ZnCl2 centrifugation and sedimentation technique (0.46 vs.
0.75) [57]. This latter protocol was specifically developed to
detect E. multilocularis in fox feces [60], and is currently
recommended for large-scale screening of canid hosts [17, 57].
Without data obtained with standardized techniques of
known sensitivity, or without correcting for the differences in
sensitivity, comparisons of prevalence between regions and
across time intervals are likely to be misleading or uninforma-
tive. The technique adopted can also affect estimates of para-
site intensity (sensu [11]). Diagnostic challenges may also
occur when investigating prevalence in intermediate hosts.
The investigation of macroscopic liver lesions in small mam-
mals can result in an underestimation of prevalence [1], partic-
ularly when compared to histological and/or molecular tools
which are better for the detection of early larval stage infec-
tions [10, 57].
Temporal distribution of studies
The majority of the studies carried out in the NTZ are now
relatively old [67, 68, 70], with research focusing on the epide-
miology and risk factors associated with AE in highly endemic
Native American communities in Alaska [77, 82, 93].
Although pioneer studies conducted in the NCR during the
1960s and 1970s [35, 36, 72, 76] were followed by some
research effort in the 1990s and 2000s [34, 83, 85], large tem-
poral gaps between studies make evaluation of trends very dif-
ficult, if not impossible. Moreover, the adoption of molecular
diagnostic techniques in the 1990s [1, 20, 61] makes compar-
isons with older studies challenging [28, 57].
Ecological communities
Differences in host communities and predator-prey rela-
tionships can affect E. multilocularis transmission. In the
NTZ, the reliance of the arctic fox on arvicoline intermediate
hosts as a food source [25] may be responsible for the high par-
asite prevalence observed in these definitive hosts [70], with
surveys finding up to 100% of tested animals infected during
a given season [24]. While coyotes and red foxes also rely
on small mammals as a food source, their broader diet and
more pronounced opportunism [16, 59] may partially explain
why prevalence values tend to be lower in the central region,
where these canid species act as the main definitive hosts.
However, differences in temperature and humidity also likely
affect parasite egg survival in the environment [91], and there-
fore, parasite transmission in the different regions [29]. More-
over, differences in host susceptibility to infection and the
pathogenicity of different E. multilocularis strains [5] may also
impact parasite transmission across eco-regions.
In summary, data available from North America are quite
heterogeneous, making it difficult to identify trends in parasite
distribution and abundance. While the hypothesis that the par-
asite’s range is expanding across North America fits with avail-
able information [39], further supportive data are required.
Therefore, additional studies using comparable sampling
designs and diagnostic techniques are needed.
Echinococcus multilocularis in domestic
hosts
Dogs as definitive hosts
Both domestic dogs and cats can serve as definitive hosts
for E. multilocularis, albeit cats seem to play an insignificant
role in maintaining the life cycle [43]. However, unlike cats,
dogs have also been reported to become infected with the lar-
val stage of the parasite [41]. Limited information is available
on the extent to which dogs act as definite hosts of E. multiloc-
ularis in North America since very few systematic studies have
been carried out addressing this question. One notable excep-
tion is the north-western region of Alaska, in particular
St. Lawrence Island, where E. multilocularis was found in
the local dog population [22, 82, 93]. Here, on postmortem
examination, the infection prevalence in dogs residing in spe-
cific Native American communities was up to 12% [77].
Consequently, owning a dog and living in close proximity to
dogs was identified as a risk factor for human AE [82, 93].
To control AE on St. Lawrence Island, a control program
focusing on the monthly administration of praziquantel to dogs
was initiated. The prevalence of infection in intermediate hosts
was used as a measure of success, with an 83% reduction in the
prevalence in voles achieved over a 10-year period [69]. This
decrease in intermediate host prevalence helped confirm the
hypothesis that domestic dogs were contributing to the mainte-
nance of the parasite life cycle. To the best of our knowledge,
to date no other studies in North America on the prevalence in
domestic dogs harboring adult E. multilocularis have been
published, except for the ones from St. Lawrence Island,
although the latter was a unique situation and not really com-
parable to the situation in the continent obtained within our
laboratory. Based on the screening of 218 dog fecal samples
from Calgary, Canada, using a modified centrifugation and
sedimentation protocol followed by molecular confirmation
[57], we estimated an E. multilocularis prevalence of approxi-
mately 0.46% (1/218). The positive dog was regularly walked
in a known high endemic area in the city of Calgary (Alberta,
Canada; [57]) and had a history of preying upon rodents
(Massolo, Klein et al. unpublished data).
Cats as definitive hosts
In North America, only a few studies have investigated the
presence of E. multilocularis in cats. A study in Saskatchewan,
Canada reported three positives out of 131 (2.29%) sampled
free roaming cats [94]. The infected cats all had low intensity
infections (30–50 adult worms). Around the same time, addi-
tional three cats were found to harbor adult E. multilocularis
infections [54]. After finding an infected house mouse, in the
same area, the existence of a possible domestic life cycle
was hypothesized, but the alternative hypothesis that these
domestic hosts were just spill-over cases was considered.
However, although it is still controversial, it should be noted
that cats are not optimal hosts for E. multilocularis and they
are not believed to play a significant role in the parasite’s life
cycle [43].
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Dogs as aberrant intermediate hosts
Rarely, dogs can develop AE with severe hepatic lesions.
Recently, three dogs with AE were identified in Canada.
One dog was identified in British Columbia [65], a second in
Southern Ontario [64], and the third was found in Saskatoon
(Audrey Tataryn, personal communication). The occurrence
of these cases can either be an indicator of the spread of the
disease or as a consequence of a heightened awareness of
the disease following the first case report in 2012.
Human infections with Echinococcus
multilocularis in North America
While E. multilocularis is known to be endemic in northern
regions of North America, there have been few human cases
reported in the literature. The most widely documented cases,
in this region, occurred on St. Lawrence Island, Alaska, USA
starting in the 1940s [69]. In this endemic focus, working dogs
were found to be eating infected small mammals and, subse-
quently, infecting humans. Concentrated control efforts aimed
at dog deworming were able to eventually control this outbreak
[93].
Besides the more than 70 cases reported on St. Lawrence
Island, there have only been two locally acquired human AE
cases from North America described in the literature. The first
reported case was a 54-year-old fisherman from Winnipeg,
Manitoba, Canada who presented with an abdominal mass in
1928 [38]. The patient was operated on in 1928, but suc-
cumbed to his disease in 1935. While this case was believed
to be due to AE based on lesion morphology, no molecular
confirmation was ever performed. The second reported case
was a 56-year-old female from Minnesota, USAwho presented
for abdominal pain in 1977 [26]. In a 2008 publication, molec-
ular evaluation of the cyst material obtained from the Minne-
sota case was shown to be almost identical to other isolates
collected from intermediate hosts in South Dakota, USA
[95]. A recent comparison of the mitochondrial gene cox1
sequence from an isolate from the Minnesota case with
sequence data from adult worms collected from red fox in
Indiana, USA [45] confirmed that the Minnesota case was
infected with the North American N2 strain as described by
Nakao and colleagues [62].
In May 2013, AE was reported in an immunosuppressed
patient from Edmonton, Alberta, Canada, who had no history
of travel (personal communication, Kinga T. Kowalewska-
Grochowska). This case requires special consideration since
immunosuppressed patients can be considered sentinels for
locally emerging diseases. In a recent publication from France,
a statistically significant increase in the number of immuno-
suppressed AE cases was described over the period 2002–
2012 [15]. This report also indicated that the presence of
immunosuppression may make AE cases more difficult to
diagnose and treat.
A recent search of Canadian hospital discharge data,
provided by the Canadian Institute for Health Information
(CIHI) for the years 2001–2014, identified 242 hospital dis-
charges with International Classification of Diseases-version
9 (ICD-9) codes for cystic echinococcosis (n = 39), alveolar
echinococcosis (n = 12), or unspecified echinococcosis
(n = 191) (Table 2, Fig. 1). These data indicate that Canadian
healthcare providers have been treating cases of echinococcosis
for many years. However, from this type of data, it is not pos-
sible to differentiate cases that were acquired locally from
those that were acquired outside of North America. Large pop-
ulation centers, with considerable immigrant populations from
known endemic regions, are likely to be areas with the highest
numbers of identified cases. Considering the high level of
immigration in North America, most of these cases are likely
to have been acquired on other continents, and not represent
autochthonous infections (e.g. [66]). This is not uncommon for
countries characterized by high immigration rates. For exam-
ple, in a study conducted in Germany, only nine out of 65
cystic echinococcosis cases were of German origin [63].
In another German study, AE was diagnosed in a refugee from
an endemic area (e.g. [86]).
Based on ICD-9 data alone, it is not possible to assess how
many individuals the 242 hospital discharges actually repre-
sent, or to confirm the provided diagnosis. In addition, the
infecting species was recorded for only a small proportion of
the hospital discharges. That said, for the last decade, there
has been an average of 19 discharges per year at hospitals
located in all Canadian provinces except for Quebec, with no
obvious upward or downward trend in case numbers. When
the number of hospital discharges coded for unspecified liver
disease was evaluated, for the same time period, there also
did not appear to be an upward or downward trend in these
case numbers.
A review of the available human data from North America
indicates that there continues to be little known about the
impact of human AE on this region. A lack of official reporting
mechanisms means that, if cases are occurring, they are not
being centrally recorded. In addition, it is possible that physi-
cians in Canada and the USA may be misdiagnosing cases due
to lack of training about the disease and its presentation. There-
fore, a retrospective study evaluating banked liver tissue sam-
ples available from health service agencies (e.g., the Alberta
Provincial Laboratory for Public Health in Alberta, Canada)
would be helpful in assessing if cases of hepatic AE are being
misdiagnosed [81]. Establishment of multidisciplinary teams
composed of public health personnel, physicians, veterinarians,
wildlife biologists, laboratory personnel, molecular biologists,
epidemiologists, and ecologists is needed to develop a current
picture of E. multilocularis transmission and the human health
impact of AE on North America.
Distribution of strains: the effect
of globalization?
Information on the distribution of differentE.multilocularis
genotypes is needed to assess possible introductions that might
have occurred in the last decades [18], as well as to evaluate
the public health risks associated with different genotypes.
Since the 1990s, isolates obtained from definitive and interme-
diate hosts originating from distinct geographical regions have
been analyzed with respect to genetic differences. Analyzing a
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471 base pair region of NADH dehydrogenase 1, Bowles and
McManus [7] identified two genotypes (M1 and M2). M1 was
identified in specimens from China, Alaska, and central North
America, while M2 was found in a single European isolate.
Based on polymorphism of microsatellites in the U1 snRNA
gene of 41 isolates, Bretagne and co-workers described three
distinct profiles of which profile A was found in all isolates
from Europe, profile B was found in isolates from Alaska
and Japan, and profile C was associated with isolates from
Alaska and Montana [8]. Haag and co-workers analyzed the
variance of two coding and two non-coding regions of the
E. multilocularis genome [32] in 33 isolates and found minor
differences in the intron of a homeobox-containing gene.
Genotype A was found worldwide, whereas genotype B was
restricted to St. Lawrence Island, Alaska.
The tandem repeat multilocus microsatellite EmsB exhibits
a high genetic polymorphism, resulting in this genetic marker
having a higher discriminatory power compared to others.
Twenty-nine distinct genotypes have been identified [4, 46].
Nakao et al. described the division of 76 isolates into three dis-
tinct branches based on their geographical origin (Europe,
Asia, or North America). Within the European, Asian, and
North American clusters, 5, 10, and 2 haplotypes were identi-
fied, respectively [62]. To our knowledge, no isolates from
autochthonous North American AE cases have been
genotyped.
In 2009, a new haplotype was discovered which has simi-
larities to previously described European haplotypes [27]. This
new haplotype was found in foxes and coyotes from rural sites
in three different Canadian Provinces (British Columbia,
Alberta, and Saskatchewan). Thus far, this new haplotype
has not been found in intermediate hosts. More recently,
Massolo, Klein, and colleagues (unpublished data) found that
this newly identified European strain was circulating in both
urban (Calgary and Edmonton, Alberta, Canada) and rural
environments. This poses interesting questions on the spread
of this European strain into an area of known endemicity for
the N2 strain and the possible public health risks.
The presence of this European strain in western Canada
might be explained by two hypotheses. The first hypothesis
is that the appearance of this new strain occurred as a conse-
quence of introducing foxes from Europe for commercial use
[18, 19]. The second hypothesis is that the parasite was intro-
duced with dogs imported from Europe. Canada does not
require treatment of dogs with praziquantel before entering
the country. A recent risk assessment on importation of dogs
infected with E. multilocularis into the United Kingdom
pointed out that without the required treatment of dogs with
praziquantel, it would be impossible to prevent the introduction
of this parasite [87, 89]. The proposed hypotheses are not nec-
essarily mutually exclusive, as they both could have occurred
at different times and in different areas. At present, there is
Table 2. Canadian hospital discharge data on Cystic Echinococcosis (CE), Alveolar Echinococcosis (AE), unspecified Echinococcosis and
unspecified liver diseases for the period 2001–2014 by year and province. Data from Quebec were not available.
Year CE AE Unspecified Echinococcosis Unspecified Liver disease
2001–2002 1 0 4 64
2002–2003 0 1 11 199
2003–2004 3 0 10 150
2004–2005 7 0 7 164
2005–2006 3 4 16 152
2006–2007 4 3 19 179
2007–2008 3 0 18 181
2008–2009 1 0 18 143
2009–2010 3 2 10 150
2010–2011 7 1 24 136
2011–2012 3 0 21 153
2012–2013 2 1 17 160
2013–2014 2 0 16 118
*Canadian Province
AB 11 5 37 163
BC 3 2 40 568
MB 4 0 14 138
NB 0 0 1 103
NL 1 0 3 58
NS 0 0 4 119
NT 0 0 0 5
NU 0 0 0 1
ON 17 4 79 644
PE 0 0 0 37
SK 3 1 13 105
YT 0 0 0 8
Total 39 12 191 1949
*AB-Alberta, BC-British Columbia, MB-Manitoba, NB-New Brunswick, NL-Newfoundland and Labrador, NS-Nova Scotia, NT-Northwest
Territories, NU-Nunavut, ON-Ontario, PE-Prince Edward Island, SK-Saskatchewan, YT-Yukon. Data not available for Quebec.
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not enough information to support either hypothesis. However,
the implementation of a praziquantel treatment policy for dogs
being imported into North America would reduce the risk of
introducing additional European strains.
Conclusions and perspectives
Considering what is available in the literature on E. multi-
locularis ecology and epidemiology in North America, it is
clear that there are substantial knowledge gaps. Available data
are not spatially and temporally homogenous and differences in
diagnostic methods and sampling design make comparisons
difficult. Current hypotheses on parasite spread and the inva-
sion of new strains are not yet sufficiently supported by data.
In most cases, the presence of E. multilocularis in domestic
animals is not monitored and its prevalence is not known even
in settings where zoonotic transmission is more likely to occur
(e.g., urban landscapes). The aggregation of thousands of pets
in city parks and the presence of potentially infected coyotes,
foxes, and small mammals should induce city managers and
health authorities to assess the risk of transmission to dogs
and humans. Despite their poor suitability as hosts for E. mul-
tilocularis, the role of cats as a potential route of infection to
people should also be assessed. Reports of dogs acting as
aberrant intermediate hosts have recently received increased
attention in Canada, with these cases possibly representing a
change in the relevance of E. multilocularis from an animal
health standpoint.
The presence of a European strain of E. multilocularis in
Canada, the discovery of a highly endemic area in Calgary,
and the recent diagnosis of AE in an immunosuppressed
patient in Edmonton suggest that we might expect to see an
increase in the number of human cases in North America, sim-
ilar to what has been seen in Central Europe [18]. Additional
data are needed to help decide whether to develop new policies
on wildlife management in urban settings and/or importation
of dogs from areas where highly pathogenic strains of E. mul-
tilocularis are endemic. We feel that it is a priority to imple-
ment the following actions: (1) to assess the prevalence of
E. multilocularis in wild and domestic hosts, in well-defined
ecosystems, through long term studies with comparable sam-
pling designs and diagnostic protocols, (2) to assess whether
cases of human AE have been misdiagnosed through a retro-
spective analysis of biological samples available in the bio-
banks of health service agencies, and finally (3) to develop a
surveillance plan for human AE in North America. This would
require the efforts of a multidisciplinary working group engag-
ing parasitologists, ecologists, public health officers, patholo-
gists, surgeons, veterinarians, epidemiologists, and others to
increase preparedness and develop possible control and disease
management strategies.
Figure 1. Distribution map by Province of Canadian hospital discharge data of Cystic Echinococcosis (CE), Alveolar Echinococcosis (AE),
unspecified Echinococcosis and general liver diseases in Canada for the period 2001–2014. Data for Quebec were not available. Map by
K. Berger, 2014.
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